GET THE APP
Barbara Tettenborn Swaziland
Commentary Alemtuzumab: The Right Choice in the Management of Relapsingremitting Multiple Sclerosis? Author(s): Murat Yildiz and Barbara TettenbornMurat Yildiz and Barbara Tettenborn
DOI: 10.4172/2155-9562.1000196
PDF